Spanish Red Biotech Pipeline

Gilead Sciences

Sacituzumab govitecan-hziy + pembrolizumab

Type: Biodrugs/ Drugs
Therapeutic area: Cancer
Indication: 1L non-small cell lung cancer
Phase: 2Phase II in Spain, 1Phase I in Spain